| Abstrakt: |
A recent report from the University of Catania in Italy highlights the growing concern of Acinetobacter baumannii in hospital settings, particularly among critically ill patients. The bacterium's ability to develop resistance to antibiotics is a significant challenge, and current antimicrobial agents are becoming less effective. Researchers are exploring alternative therapeutic approaches, such as combination drugs and novel molecules, as well as the potential of phage therapy and artificial intelligence. The fight against A. baumannii requires a coordinated global response, as it is a broader public health issue. [Extracted from the article] |
